推荐微信扫码登录以获得更好的体验!另:🎉建议更新到最新版,以体验新功能!🎉 版本更新记录→

告别“千人一方”!莫德纳CEO揭秘mRNA癌症疫苗:如何给免

字幕摘录

时间英文中文
0:00Shares of Moderna and Merck are surging this morning, and that is no exaggeration.Modena和Merck的股份 今天早上正在猛增, 这并不是夸张。
0:05Check it out.检查出来。
0:06Shares of Merck right now up by about seven and three-quarters percent, of course, beforeMerck的股权现在上升了 大约七和四分之三, 当然,在之前
0:10those moves.这些动作。
0:11This was a company with a $333 billion market cap, so that is substantial when you're talking这家公司有3,330亿的市场上限, 所以当你说话的时候,这是实质性的
0:15numbers.数字。
0:16然后检查Moderna的股份.
0:18They are up 63 percent, a gain of close to $40 right now.他们上升了63%, 近40美元的收益现在。
0:23Stock is now trading at $102.现在股票交易额是102美元。
0:25By the way, before that move, that was a stock with about a $25 billion valuation, so you're顺便说一句,在移动之前, 这是一个股票 约250亿美元估值, 所以你是
展开字幕全文(133 条)
序号英文中文
1Shares of Moderna and Merck are surging this morning, and that is no exaggeration.Modena和Merck的股份 今天早上正在猛增, 这并不是夸张。
2Check it out.检查出来。
3Shares of Merck right now up by about seven and three-quarters percent, of course, beforeMerck的股权现在上升了 大约七和四分之三, 当然,在之前
4those moves.这些动作。
5This was a company with a $333 billion market cap, so that is substantial when you're talking这家公司有3,330亿的市场上限, 所以当你说话的时候,这是实质性的
6numbers.数字。
7然后检查Moderna的股份.
8They are up 63 percent, a gain of close to $40 right now.他们上升了63%, 近40美元的收益现在。
9Stock is now trading at $102.现在股票交易额是102美元。
10By the way, before that move, that was a stock with about a $25 billion valuation, so you're顺便说一句,在移动之前, 这是一个股票 约250亿美元估值, 所以你是
11probably talking $38 to $40 billion now of valuation in the company today.大概是38亿到400亿美元 今天在公司的估值。
12All of this is because of a Phase III study that found the combination of mRNA-based individualized所有这一切都是因为第三阶段的研究 发现了基于mRNA的个体化
13neoantigen therapy, or INT, combined with Merck's Keytruda, reduced the risk of recurrence抗原疗法,或INT,结合默克的Keytrada,降低了复发的风险
14or death in melanoma patients in a Phase II and Phase III trials that they've been running.或者在二期和三期试验中死于黑色素瘤患者
15现在加入我们 更多关于这个的 是Modena的首席执行官Stephane Bensel和Dean Lee博士
16is the president of Merck Research Laboratories, and gentlemen, welcome to both of you.是Merck研究实验室的总裁 先生们 欢迎你们两位
17Thank you very much.谢谢
18Before we talk numbers and markets and the rest of this, let's talk about what this means在谈数字和市场之前 谈其他的,我们谈谈这意味着什么
19on the human level, what you found with these studies, increasing survival and not only在人类层面上,你通过这些研究发现了什么, 提高了生存, 不仅仅是
20increasing survival, but reducing recurrence of cancer for patients who had melanoma that增加存活率,但减少患黑色素瘤的患者的癌症复发
21was cut out, and then they were treated at the same time with this gene therapy vaccine.然后用基因治疗疫苗同时治疗
22Let's talk about it.师便打.
23Stephane, you've been working on this for a very long time.史黛芬,你一直在研究这个
24Yes, Becky, thank you for having us.是的,贝琪,谢谢你邀请我们。
25For 10 years, I will let, you know, my colleague Dean talked about the science, he's the doctor,10年来,我会让,你知道, 我的同事迪安谈论科学, 他是医生,
26but basically the way we think about it, it's like November 16, 2020, when we're on the但基本上我们的想法, 这就像2020年11月16日, 当我们在
27Phase III of COVID, of vaccine, you remember, we were on the show that morning.COVID的第三阶段,疫苗,你记得, 我们那天早上在节目。
28It's a big moment for medicine, a big moment for patients.医之大关,病人之大关.
29我们认为这只是Intismarin + Ketudra的第一步。
30We're excited what it is going to mean for patients already.我们很兴奋这对病人的意义
31Just hearing stories from patients in clinical studies has been really heartening.刚刚听到病人的故事 在临床研究中 真的很令人振奋。
32And so, I'm very thankful for the team that have worked on this for 10 years.因此,我非常感谢 10年来一直致力于这项工作的团队。
33That's the type of things we're trying to do at Moderna, is take very big scientific这就是我们在Moderna的尝试, 采取非常大的科学
34clinical bets, look at mRNA was a big bet, COVID doing a vaccine in a year was a big临床赌注,看mRNA 是一个大赌注,COVID 做疫苗在一年是一大
35bet.赌
36This is a big bet with a few more coming, but this one is going to be very, very profound这下赌注要再赌几下 但这次会很深
37and impactful.并且影响很大。
38And all of us have been touched by cancer.我们所有人都被癌症感动了。
39Many of us are being touched by cancer now in our family or loved ones.我们许多人现在受到家庭或亲人癌症的影响。
40And so, just what it means for patients is what gets us so excited.所以,对于病人来说, 就是是什么让我们如此兴奋。
41Dr. Lee, let's talk about this particular study.李博士,我们谈谈这个研究
42I think it was 1,100 patients involved.我想有1100个病人参与
43Yeah, so what's exciting about it is you're taking ketruda, which many people know is是啊,所以什么是令人兴奋的是,你正在服用 Ketruda,
44a really important cancer drug that's approved in 20 different types of cancers.一种非常重要的癌症药物 在20种癌症中得到批准
45And if you add this personalized cancer treatment based on the technology of Moderna, and you如果你根据现代技术 加入这种个性化的癌症治疗, 而你
46treat patients with a really deadly disease, melanoma, you reduce that risk of recurrence,治疗患有致命性疾病、黑色素瘤的病人, 减少这种复发的风险,
47which essentially means that patients have a better chance of being disease-free and基本上意味着病人有更好的机会无疾病,
48for longer.更长时间。
49And the question will arise as to how long could they be disease-free.并会出现一个问题,即它们能有多久没有疾病。
50So we're going to run this trial out and see, but we have a hint.所以,我们要去运行 这个试验出来看看, 但我们有一个提示。
51We did a phase two some years ago, Moderna and Merck.我们做了一个阶段 几年前,现代和默克。
52And what we said is after that treatment, after patients were treated, we would look我们说的是在治疗之后, 在病人被治疗之后,我们会寻找
53one year.一年时间。
54How many people are disease-free?有多少人没有疾病?
55Three years.三年..
56And I think the five-year results just were provided out there.我认为,五年的结果只是在那里提供的。
57And what you saw at five years is that many, I would actually say most of the patients你五年来看到的是 这么多人,我可以说大多数病人
58who are disease-free one year, three years, were disease-free five years.他们没有疾病一年,三年, 没有疾病五年。
59So we don't know if this is going to be seven years, nine years, but there's a chance that所以我们不知道这会不会是7年,9年, 但有可能
60you have an increased race, increased ability to be disease-free and for a potentially extended您有更大的种族, 提高能力 无疾病 和潜在的延伸
61period of time.期限。
62Tell us the results of these latest phase one and phase two trials, or phase two and告诉我们这些最新第一阶段和第二阶段、第二阶段和
63phase three trials, and what that means in the life of a patient versus if they had not第三阶段的试验,以及这在病人的生活中意味着什么?
64had this Keytruda and Merck, Keytruda and Moderna.有这个凯特鲁达和默克,凯特鲁达和现代。
65The way that I would look at it is if you didn't get the treatment with Keytruda and我的看法是 如果你没有得到治疗 与Keytrada和
66the personalized cancer treatment, we already know from phase two that you had a marked个人化的癌症治疗,我们已经知道 从第二阶段,你有一个标记
67improvement in having a chance of being disease-free.改善无疾病的机会。
68It was in the 40 to 50% from that phase two.从第二阶段开始,它处于40%到50%的水平。
69And what we know from that phase two is that-我们从第二阶段了解到的是...
7040 to 50% chance of having a reduced risk, right?40%到50%的机会 降低风险,对不对?
71And then all of a sudden you get to, we've tracked that for the phase two, five years然后突然间,我们跟踪了第二,五年
72out, it's still there.出来,它仍然在那里。
73So we're hoping that very similar results come out for the phase three.所以我们希望第三阶段能得出非常相似的结果。
74You didn't give specific numbers for these-你没有给出这些具体的数字...
75Yeah, we didn't give out specific numbers.是的,我们没有给出具体的数字。
76You said that at the end point of the trials.你在审判结束时说的
77Yeah, we don't give out specific numbers because the things that we have to do immediately是啊,我们不给出具体的数字 因为我们必须立即做的事情
78and we're focused on it is we have to get all the detailed data out to the community,我们的焦点是 我们得把所有详细数据 都传到社区
79the community of oncologists and scientists, and we're planning to do it at a major oncology肿瘤学家和科学家们 我们计划在一个主要的肿瘤学领域
80meeting hopefully this fall and also get that data out through a really respected journal.希望今年秋天能见面 并且通过一个真正受人尊敬的日记把数据拿出来
81And that will have all the details such that people can really interrogate.这些细节可以让人真正接受审讯。
82I think also in the next few months that we're going to be talking to regulatory agencies我想在未来几个月里 我们也会和监管部门谈谈
83because they're going to want to scrutinize our clinical data.因为他们要检查我们的临床数据
84And they're not going to just want to scrutinize our clinical data.他们不会只想仔细研究我们的临床数据。
85They're going to want to scrutinize this novel technology that Moderna has put in to make他们想仔细研究一下现代人发明的新科技
86that it's as efficacious and safe for broader use.这是有效和安全的 更广泛地使用。
87Well, let's talk about that.好吧,让我们谈谈这个。
88Keytrada是癌症的奇迹药
89It's been an amazing inclusion to the toolbox for fighting cancer.它是一个惊人的 包含在工具箱 抗癌。
90Different than chemotherapy because Keytruda actually uses your body's immune system和化疗不同 因为Keytrada实际上利用了你的身体免疫系统
91to go and fight the cancer itself.去对抗癌症
92Describe what this new therapy does on top of that, putting Keytruda together with this.描述一下这个新疗法的功能 将Keytrada和这个放在一起
93The idea of this actually is from the Upper East Side 130 years ago.这个想法其实是130年前的上东城.
94And the concept is if you could train your immune cells to be like hunting dogs, chasing概念是,如果你能训练你的免疫细胞 像猎狗,追逐
95the tumor, and you could unleash them.肿瘤,你可以释放它们。
96But not only could you unleash them, if you could entrain them to smell out that prey,但你不仅能释放它们 如果你能把猎物吸出来
97that would be something.那会是什么东西。
98And so in the last 10 years, that's what this result does.所以在过去的十年里, 这个结果就是这样的。
99Keytrada做的是钥匙
100It's a Keytruda.是凯特鲁达
101It unlocks the key to let the hound dogs out, let the dogs out.它打开了钥匙 让猎犬出来,让狗出来。
102But what's critical about the technology that Moderna has created is it's a personalized但现代科技最关键的是 它是一个个性化的
103cancer treatment that allows the immune cells to get the scent, the signature.癌症治疗,可以让免疫细胞得到气味,特征.
104Because it's trained on your own.因为那是你自己训练的
105On your own.独自一人.
106It's personalized medicine.个性化药.
107It's trained on your tumor.它训练你的肿瘤。
108Your cancer.你的癌症。 。 。
109Yes, I would even say it's individualized because personalized medicine is if you and是的,我甚至会说它是个性化的 因为个性化的医学是如果你和
110I have the same mutation, we might get the same drug.我有同样的突变, 我们可能会得到同样的药物。
111It's individualized, which is you will get a different drug.这是个性化的,你会得到不同的药物。
112If you're diagnosed with melanoma today, and I'm diagnosed by the same doc, you and I will如果你今天被诊断患有黑色素瘤 而我被同一位医生诊断
113get a different chemical.换个化学物质
114Basically, we're going to look at you, take a biopsy, we're going to sequence all the基本上,我们要看着你, 做个活体检查, 我们要排序所有
115letter of the DNA of your cancer cell, we're going to do the same for your healthy cell你癌细胞的DNA信 我们也会为你的健康细胞做同样的事情
116of your body, most blood work, we're going to compare electronically where the mutations在你身体里,大部分的血液工作, 我们要比较电子 哪里的突变
117are and we designed and we aim to improve an algorithm to pick 34 mutations that we我们设计了一个算法 用来选择34个变异
118believe are the most important in your tumor.相信是肿瘤中最重要的
119We put that into one molecule of mRNA, we stitch them together, and we inject that to我们把它放进一个分子的mRNA, 我们把它们缝合在一起,我们注射到
120you in your arm, and that's what Dean was just saying, that's to give your immune system,迪恩刚才说的 就是给你的免疫系统
121to give to the docs, to give the serology.给医生,给血清学。
122It's the personalized medicine.这是个性化的药。
123Amazing.厉害
124This is the demonstration of the future.此是示现未来.
125Yes, it's totally individualized using sequencing technology at the molecular level because是的,它完全个性化 使用分子级的测序技术 因为
126we know today cancer is a disease of DNA, and that's why it's so powerful.我们知道癌症是DNA的疾病 所以它才如此强大
127Does that make it safer in terms of whether the immune system attacks other organs that就免疫系统是否攻击那些
128don't need to be attacked?不需要被攻击吗?
129The hope is there, and the data that we saw from the previous over five years, it's safe5年来我们所看到的数据是安全的
130and people are going to scrutinize this data and they're going to watch it.人们会仔细检查这些数据 然后他们就会看
131And I think the FDA and the community will say this is a safe drug that really is efficacious我想FDA和社区会说 这是安全药 真的很有效
132and a patient population that's facing a deadly design, and a patient population that's facing面对致命设计的病人 面对的病人
133a deadly design, and a patient population that's facing a deadly design, and a patient一个致命的设计,一个病人 面对一个致命的设计,一个病人
该视频共有字幕 133 条。解锁更多字幕为会员功能,请移动到 价格